Tandem Diabetes Care Inc.
05/23/2024 | Press release | Distributed by Public on 05/23/2024 14:30
Submission of Matters to a Vote of Security Holders - Form 8-K
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
(e)
On May 22, 2024, the stockholders of Tandem Diabetes Care, Inc. (the "Company") approved the Company's 2013 Employee Stock Purchase Plan, as amended, and the Company's 2023 Long-Term Incentive Plan, as amended, as described in Item 5.07 below. A summary of the principal features of the Company's 2013 Employee Stock Purchase Plan, as amended, is set forth under the heading "Proposal 2 - 2013 Employee Stock Purchase Plan, as Amended" contained in the Company's definitive proxy statement on Schedule 14A, filed with the Securities and Exchange Commission on April 9, 2024 (the "Proxy Statement"). A summary of the principal features of the Company's 2023 Long-Term Incentive Plan, as amended, is set forth under the heading "Proposal 3 - 2023 Long-Term Incentive Plan as Amended" contained in the Proxy Statement.